Firms

Mission Bay Capital

San Francisco, California, United States

Mission Bay Capital is a San Francisco early-stage life-science venture investment platform founded in August2009 to support bioscience entrepreneurs emerging from the University of California and other research institutions. It operates alongside MBC BioLabs shared laboratory infrastructure and funds biotechnology, medical diagnostics, therapeutic discovery and other research-derived technologies. The original brand is related to Mission BioCapital but remains a distinct historical fund platform: its own landing page separately links Mission Bay Capital and Mission BioCapital, while the March9,2023 QurAlis issuer explicitly names both investors. The relationship does not establish that they made the same check. Current2026 SEC filings distinguish FundI adviser Mission Bay Capital Management Inc (CRD288916), FundII adviser MBC FII Management LLC (CRD289161) with Mission Bay Capital Management LLC as fundmanager, and FundIII adviser Awesome Enablers LLC (CRD298755) with GP MBC Management III LLC. Those filings separately list Mission BioCapital Management Company LLC as a related adviser; shared team/ownership is not a legal merger. The brand profile groups its own historic Mission Bay vehicles with explicit per-fund adviser identities, and does not represent the separate Mission BioCapital FundI/V/VI as Mission Bay capital. CurrentMarch2026 filings confirm Douglas Kingsley Crawford and Robert Glenn Blazej in the relevant management rosters. The undated public website publishes five management/operations people and six outside investment advisory committee members; those advisory affiliations and historical outside titles are not presumed current fund employment. SEC adds Regis Kelly as FundI manager President. Relevant primary institutional financing includes QurAlis ALS/FTD precision-therapy research. FundI launched with USD7.5M disclosedOctober26,2009, an initial launch amount rather than a final later total; FundII USD25M is retrospectively confirmed by the2019 own release with finalclose day unpublished; FundIII actually closedUSD60M announcedSeptember16,2019. Its master and Cayman feeder are recorded separately but capital is counted once at the master; grossassets/portfolio financing/LP commitments are not new fund cash. Exact QurAlis2023 fund allocation and institutional ticket remain undisclosed. Mission Bay Capital Partners real-estate syndication is unrelated.

Founded: 2009
Type: Venture capital

Funds4

Mission Bay Capital III, L.P.2019-09-162019-09-16$60M
ActualFundIII60MclosedSeptember16,2019 primaryannouncement. Current2026master805-9712143955 advisedAwesomeEnablersLLC298755 withGPMBCManagementIIILLC. Master-feederstrategycapitalcountedoncehere, feederadditionalcashnotinferred.
Mission Bay Capital, LLC (Fund I)2009-10-262009-10-26$7M
First fund805-8961628091, originalmanagerMissionBayCapitalManagementInc288916. UCSF launchdisclosed7.5MOctober26,2009, initiallaunchcapital snapshot notassertedfinalclose. Later11.3M totalunverifiedexactdateandexcludedduplicatecash.
Mission Bay Capital Fund III Feeder, LP——
Caymanfeeder805-5280258041 forMissionBayCapitalIII master805-9712143955; current2026ADV GPMBCManagementIIILLC, adviserAwesomeEnablersLLC. Separatelegalvehiclebutshares60Mstrategycapitalrecordedonceonmaster; feederamount/closedayNULL, noadditionalraise.
Mission Bay Capital II, L.P.—$25M
FundII805-7618748646 advisedbyMBCFIIManagementLLC289161, GPmanagementMissionBayCapitalManagementLLC. Actualpriorfund25Mretrospectivelyconfirmed2019ownrelease; exactfinalclosedayundisclosed. No grossassetfiguretreatedasnewcash.